Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment naïve”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01313559
What this trial is testing

Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate Cancer

Who this might be right for
Castrate Resistant Prostate CancerChemotherapy Naive Prostate CancerProstate Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 6
Post-approval studies (Phase 4)Looking for participantsNCT06671587
What this trial is testing

IGlarLixi CGM Study in Chinese T2D Individuals After OADs

Who this might be right for
Type 2 Diabetes (T2D)
Sanofi 678
Testing effectiveness (Phase 2)Study completedNCT02077634
What this trial is testing

Trial of Abiraterone Acetate Plus LHRH-therapy Versus Abiraterone Acetate Sparing LHRH-therapy in Patients With Progressive Chemotherapy-naïve Castration-resistant Prostate Cancer (SPARE)

Who this might be right for
Prostate Cancer
Universität des Saarlandes 68
Testing effectiveness (Phase 2)Study completedNCT02489344
What this trial is testing

Evaluation of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-Naïve Adult Male Patients With Fabry Disease

Who this might be right for
Fabry Disease
Genzyme, a Sanofi Company 8
Post-approval studies (Phase 4)UnknownNCT02525172
What this trial is testing

Immune Modulation Therapy for Pompe Disease

Who this might be right for
Pompe Disease
National Taiwan University Hospital 8
Post-approval studies (Phase 4)Study completedNCT00207142
What this trial is testing

Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study)

Who this might be right for
HIV Infections
Bristol-Myers Squibb 252
Testing effectiveness (Phase 2)Study completedNCT00711230
What this trial is testing

Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients

Who this might be right for
HIV Infection
Genetic Immunity 36
Large-scale testing (Phase 3)Ended earlyNCT00423800
What this trial is testing

Efficacy and Safety of 24 vs 48 Weeks of Pegetron® (Peginterferon Alfa-2b + Ribavirin) in Naïve Genotype 1 Hepatitis C (Study P05016)(TERMINATED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 56
Not applicableEnded earlyNCT00705107
What this trial is testing

Adherence to Treatment With PegIntron Pen Plus Rebetol in Treatment-naïve Adult Patients With Hepatitis C in Romania (Study P04247)

Who this might be right for
Hepatitis C, ChronicHepatitis C
Merck Sharp & Dohme LLC 267
Testing effectiveness (Phase 2)Active Not RecruitingNCT06565273
What this trial is testing

Study to Investigate the Efficacy, Safety, and Tolerability of FBL-MTX in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
SOLFARCOS - Pharmaceutical and Cosmetic Solutions Ltd 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03821792
What this trial is testing

Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate CarcinomaProstate AdenocarcinomaProstate Carcinoma Metastatic in the Bone+3 more
M.D. Anderson Cancer Center 60
Not applicableUnknownNCT02576236
What this trial is testing

Therapeutic Trial Comparing Triple Therapy Guided by the PCR Detection of Clarithromycin Resistance vs Empiric Concomitant Quadruple Therapy for Helicobacter Pylori Infection

Who this might be right for
H Pylori Infection EradicationAntibiotics Therapeutic StrategiesH Pylori Eradication
Assistance Publique - Hôpitaux de Paris 2,500
Testing effectiveness (Phase 2)Study completedNCT00133575
What this trial is testing

ACAM 3000 MVA at Harvard Medical School

Who this might be right for
Smallpox
National Institute of Allergy and Infectious Diseases (NIAID) 72
Testing effectiveness (Phase 2)Ended earlyNCT02065336
What this trial is testing

Study to Determine the Depth and Duration of Hepatitis B Surface Antigen (HBsAg) Reduction After Single or Multiple Doses of ARC-520, in Combination With Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection

Who this might be right for
Hepatitis B, Chronic
Arrowhead Pharmaceuticals 58
Testing effectiveness (Phase 2)Looking for participantsNCT05933967
What this trial is testing

Orelabrutinib Plus R-CHOP in Treatment-naïve Patients With Double Expression Diffuse Large B-cell Lymphoma

Who this might be right for
The First Affiliated Hospital of Nanchang University
Shandong Cancer Hospital and Institute 31
Large-scale testing (Phase 3)Study completedNCT05917509
What this trial is testing

Evaluate the Efficacy, Safety, Participant Choice and Preference of an Oral Once-daily Regimen or a Long-acting Injectable Regimen Every Two Months for Treatment of Human Immunodeficiency Virus (HIV-1) in Adults Who Have Not Previously Taken Antiretroviral Therapy

Who this might be right for
HIV Infections
ViiV Healthcare 171
Large-scale testing (Phase 3)Ended earlyNCT04840667
What this trial is testing

Replagal in Treatment-naïve Adults With Fabry Disease

Who this might be right for
Fabry Disease
Shire 17
Post-approval studies (Phase 4)UnknownNCT02404233
What this trial is testing

Open Label, Pilot Study of Darunavir Boosted by Cobicistat in Combination With Rilpivirine to Treat HIV+ Naïve Subjects

Who this might be right for
HIV Positive
Therapeutic Concepts 30
Testing effectiveness (Phase 2)Study completedNCT00993148
What this trial is testing

Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1

Who this might be right for
HIV-1 InfectionHIV Infections
Northwestern University 25
Large-scale testing (Phase 3)Study completedNCT02477826
What this trial is testing

An Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
Bristol-Myers Squibb 2,747
Next Page